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丝裂霉素 C 植入型膜剂，并对载药微球和膜剂进行理化性质的研究；通过 MTT
实验和动物实验对载药微球的药效学进行初步评价。具体研究工作摘要如下： 




圆整，粒径均匀，平均粒径可控制在 600 nm，包封率 高可达 99.0%，具有明




























剂量丝裂霉素 C 原药或丝裂霉素 C 注射剂组相比，丝裂霉素 C-聚乳酸纳米微球
组的抑瘤率更高，对肿瘤生长的抑制更为持久。  

















Sustained/Controlled release drug delivery system (SCDDS), one of the 
fast-developing technologies over the past two decades in international medical 
community, by changing the dosage form or drug delivery methods, can overcome the 
shortcomings of traditional anti-cancer drugs. S/O/O emulsion solvent evaporation 
method is a new potential preparation method for drug loaded polymer nanoparticles, 
which can effectively improve drug content and encapsulation efficiency of 
Water-soluble drug, and will have an important research significance and 
development prospect. Mitomycin C (MMC) is a broad-spectrum antitumor antibiotic 
drug. Form of medication is freeze-dried powder injection. To reduce the times of 
administration and side effects, to improve patient compliance , and to make it have 
better clinical applications, MMC-loaded nanoparticles were first prepared by S/O/O 
emulsion solvent evaporation method with the carrier of PLA, and the blank film and 
drug-loaded film were further prepared with the carrier of collagen and chitosan. Then 
we investigated the physical and chemical properties of MMC-loaded PLA 
nanoparticles and drug-loaded film, and also pharmacodynamic effects of 
MMC-loaded PLA nanoparticles through MTT experiment and animal experiments. 
The contents are summarized as follows: 
(1) Preparation and properties of MMC-loaded PLA nanoparticles: 
MMC-loaded PLA nanoparticles were prepared by S/O/O emulsion solvent 
evaporation method, and preparation techniques were optimized through orthogonal 
design. Properties of MMC-loaded nanoparticles (eg. morphological form, diameter, 
distribution, Zeta electric potential, drug content, encapsulation efficiency, in vitro 
release properties) and drug distribution in nanoparticles were investigated in this 
thesis. The results showed that the nanoparticles produced with the optimized recipes 
and preparation technique displayed smooth surface, consistent diameters, mean 















and obvious sustained-release effect in vitro release period. The chemical properties 
of MMC and PLA in the drug-loaded nanoparticles have no change. 
(2) Preparation and properties of MMC-loaded film: Collagen and chitosan 
were chosen as film materials. Blank film and MMC-loaded film were prepared and 
their properties (eg. morphological form, swelling ratio, mechanical property, the 
interaction among film materials, in vitro releasing curve) were investigated. The 
results showed that MMC-loaded film had favourable microstructure and 
nanoparticles were uniformly distributed in the film in inlaying and embedding way; 
Along with the increasing proportion of chitosan, the swelling ratio of MMC-loaded 
film gradually reduced, the tensile strength increased and the breaking elongating rate 
reduced. From infrared spectral analysis, noncovalent interactions between collagen 
and chitosan contributed together with ionic, hydrogen bonding and hydrophobic 
interactions, to the stability of the blank film. The in vitro release rate of MMC-loaded 
film was slower and more stable than MMC-loaded nanoparticles, and displayed 
favourable sustained-release effect with no burst release. 
(3) The preliminary study about pharmacodynamic effect of MMC-loaded 
PLA nanoparticles: Pharmacodynamic effect of MMC-loaded PLA nanoparticles 
was investigated by MTT experiment in vitro and H22 solid tumor animal experiment 
in vivo as well as the result of pathological section. The results suggested that not 
only in vitro but also in vivo, the inhibition effect of MMC-loaded PLA nanoparticles 
was obvious and dose-dependent and higher than that of free MMC or MMC 
injection.  
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第一章 绪 论 
1.1 缓控释给药系统 
缓控释制剂历史由来已久，例如传统医学认为蜡丸作用缓和而持久，是 早

















































 (1) 首过作用强的药物中有不少被研制成缓释及控释制剂。 
 (2) 半衰期很短或很长的药物制成缓释或控释制剂。 









 (2) 透皮给药系统制剂：药库型(reservoir system),骨架型(matrix system),微
囊型(microsealed drug delivery system)。 




















 (6) 脉冲式或自调式释药系统。 
1.2 纳米粒给药系统 
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